Accuray (ARAY) Stock Price, News & Analysis

-0.02 (-0.90%)
(As of 04/24/2024 ET)
Today's Range
50-Day Range
52-Week Range
293,900 shs
Average Volume
449,972 shs
Market Capitalization
$218.17 million
P/E Ratio
Dividend Yield
Price Target

Accuray MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
275.0% Upside
$8.25 Price Target
Short Interest
5.31% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
0.63mentions of Accuray in the last 14 days
Based on 3 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($0.07) to $0.14 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.80 out of 5 stars

Medical Sector

211th out of 907 stocks

Surgical & Medical Instruments Industry

30th out of 96 stocks

ARAY stock logo

About Accuray Stock (NASDAQ:ARAY)

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

ARAY Stock Price History

ARAY Stock News Headlines

Will this $2 AI stock double overnight?
It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!
Will this $2 AI stock double overnight?
It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!
ARAY Apr 2024 4.000 call
7 Screaming Stock Buys for Under $5
ARAY Mar 2024 2.000 call
ARAY Mar 2024 2.000 put
See More Headlines
Receive ARAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Accuray and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Equipment
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
3 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$447.61 million
Book Value
$0.56 per share


Free Float
Market Cap
$218.17 million

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

ARAY Stock Analysis - Frequently Asked Questions

Should I buy or sell Accuray stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Accuray in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ARAY shares.
View ARAY analyst ratings
or view top-rated stocks.

What is Accuray's stock price target for 2024?

3 equities research analysts have issued 1 year target prices for Accuray's stock. Their ARAY share price targets range from $7.50 to $9.00. On average, they predict the company's share price to reach $8.25 in the next twelve months. This suggests a possible upside of 275.0% from the stock's current price.
View analysts price targets for ARAY
or view top-rated stocks among Wall Street analysts.

How have ARAY shares performed in 2024?

Accuray's stock was trading at $2.83 at the start of the year. Since then, ARAY shares have decreased by 22.3% and is now trading at $2.20.
View the best growth stocks for 2024 here

When is Accuray's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our ARAY earnings forecast

How can I listen to Accuray's earnings call?

Accuray will be holding an earnings conference call on Wednesday, May 1st at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "2071766".

How were Accuray's earnings last quarter?

Accuray Incorporated (NASDAQ:ARAY) issued its quarterly earnings results on Wednesday, January, 31st. The medical equipment provider reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.05) by $0.05. The medical equipment provider had revenue of $107.24 million for the quarter, compared to analyst estimates of $107.11 million. Accuray had a negative net margin of 3.25% and a negative trailing twelve-month return on equity of 28.11%. During the same period last year, the company posted ($0.02) EPS.

What guidance has Accuray issued on next quarter's earnings?

Accuray issued an update on its FY 2024 earnings guidance on Wednesday, January, 31st. The company provided EPS guidance of for the period. The company issued revenue guidance of $460.0 million-$470.0 million, compared to the consensus revenue estimate of $463.0 million.

What is Joshua Levine's approval rating as Accuray's CEO?

107 employees have rated Accuray Chief Executive Officer Joshua Levine on Joshua Levine has an approval rating of 45% among the company's employees. This puts Joshua Levine in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 75.0% of employees surveyed would recommend working at Accuray to a friend.

What other stocks do shareholders of Accuray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Accuray investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Intel (INTC), Activision Blizzard (ATVI), Geron (GERN), Sorrento Therapeutics (SRNE), Tesla (TSLA), AbbVie (ABBV), QUALCOMM (QCOM) and ADMA Biologics (ADMA).

Who are Accuray's major shareholders?

Accuray's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Kovack Advisors Inc. (1.09%), Silverberg Bernstein Capital Management LLC (0.42%), Bridge City Capital LLC (0.12%) and Simplicity Wealth LLC (0.02%). Insiders that own company stock include Ali Pervaiz, Brandon W Green, Byron C Scott, Gina Corradetti, Jesse Chew, Joseph E Whitters, Joshua Levine, Michael Hoge, Patrick Spine, Sandeep Chalke and Suzanne C Winter.
View institutional ownership trends

How do I buy shares of Accuray?

Shares of ARAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Accuray have any subsidiaries?
The following companies are subsidiares of Accuray: Accuray Accelerator Technology (Chengdu) Company Limited, Accuray Asia Ltd., Accuray Belgium BVBA, Accuray Brasil Comércio, Accuray Cayman Islands, Accuray Europe SAS, Accuray International SARL, Accuray Italy S.R.L, Accuray Japan K.K., Accuray Medical Equipment (Canada) Ltd., Accuray Medical Equipment (India) Private Limited, Accuray Medical Equipment (Rus) LLC., Accuray Medical Equipment (Shanghai) Co. Ltd., Accuray Medical Equipment GmbH, Accuray Mexico S.A. de C.V., Accuray Netherlands B.V., Accuray Spain S.L.U., Accuray UK Ltd., Morphormics Inc., and TomoTherapy Incorporated.
Read More
This page (NASDAQ:ARAY) was last updated on 4/25/2024 by Staff

From Our Partners